Auditory neuropathy: a potentially under-recognized neonatal intensive care unit sequela

Area of Science:

• Pediatrics
• Audiology
• Neonatology

Background:

• Auditory neuropathy (AN) is a distinct hearing disorder affecting newborns.
• High-risk infants, including those with specific neonatal histories, family hearing loss, and hyperbilirubinemia, are most susceptible.
• Current neonatal intensive care unit (NICU) hearing screenings using only otoacoustic emissions are insufficient for AN detection.

Purpose of the Study:

• To highlight the diagnostic challenges and clinical significance of auditory neuropathy in newborns.
• To emphasize the need for improved screening and diagnostic methods for AN.
• To inform healthcare professionals, particularly NICU nurses, about AN's characteristics and management.

Main Methods:

• Review of audiologic evaluation findings diagnostic of AN.
• Discussion of potential pathophysiological mechanisms, including demyelination and neural degeneration.
• Analysis of AN prevalence in high-risk infant populations.

Main Results:

• Auditory neuropathy presents unique audiologic findings differentiating it from conductive and sensorineural hearing loss.
• The exact incidence of AN remains unknown but is higher in high-risk infants.
• The clinical course and outcomes of AN exhibit significant variability among affected infants.

Conclusions:

• Auditory neuropathy requires specific diagnostic approaches beyond standard NICU hearing screenings.
• Effective management strategies for AN involve close developmental monitoring and may include cochlear implantation.
• Educating families and healthcare providers about AN is essential for supporting affected infants' hearing and language development.